Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1949 of 5804
-
Time-Restricted eating may ease lingering cancer fatigue
Symptom relief CompletedThis study will assess the feasibility of delivering a 12-week time-restricted eating intervention as well as the intervention's preliminary efficacy on persistent cancer-related fatigue among cancer survivors compared to a general health education control. Participants will be r…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
CBD shows promise for social anxiety in small trial
Symptom relief CompletedThe R61 will include two CBD dose levels vs placebo (PBO) and examine potential engagement with two primary targets in a 3-week randomized controlled trial design. Willing and eligible subjects will be randomized to one of three randomized double-blind treatments (n = 20 each gro…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Beetroot juice may boost walking distance in leg artery disease
Symptom relief Recruiting nowThe BEET PAD Trial is a multi-centered double-blind randomized clinical trial designed to determine whether beetroot juice, compared to placebo, improves six-minute walk distance at four month follow-up in people with lower extremity peripheral artery disease (PAD). Investigators…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Smaller scars for breast reconstruction: endoscopic technique put to the test
Disease control CompletedThis prospective single-arm case series evaluates the feasibility, safety, and clinical outcomes of endoscopic-assisted latissimus dorsi musculocutaneous flap harvest for breast reconstruction. The study includes women with post-oncologic or post-burn breast deformities requiring…
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New blood and urine tests could spot Drug-Related pancreatitis early
Diagnosis CompletedProspective, multi-national, multi-centre observational diagnostic study of novel microRNA and protein biomarkers in peripheral blood and/or urine to detect and predict the severity of drug-associated acute pancreatitis (AP), with comparison of the same biomarkers in patients wit…
Sponsor: University of Liverpool • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
Pregnancy after Weight-Loss surgery: blood sugar swings may harm baby
Knowledge-focused Recruiting nowThe aim of the GLORIA study is to determine whether an altered glucose metabolism (with more hypoglycaemia and glycaemic variability) and altered metabolomics during pregnancy after bariatric surgery contribute to the increased risk for adverse pregnancy outcomes such as small-fo…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New ablation tools battle for better heart rhythm control
Disease control CompletedTwo non-thermal ablation techniques approved for routine clinical practice (CE-marked) for the interventional treatment of atrial fibrillation are compared in a 1:1 randomization to investigate patient data, procedural data, effectiveness, and safety.
Phase: NA • Sponsor: Alfried Krupp Krankenhaus • Aim: Disease control
Last updated Jun 26, 2026 18:19 UTC
-
New hope for epilepsy: Real-World data on Cenobamate's impact
Disease control OngoingThe BLESS Study contributes to filling this information gap by collecting data from the Italian clinical practice and the Compassionate Use Program, to better characterize the clinical profile of cenobamate describing its effectiveness, safety and tolerability in adult patients d…
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated Jun 26, 2026 15:21 UTC
-
Brain scan tracer could reveal hidden signs of psychosis in Parkinson's
Knowledge-focused Recruiting nowIt is hypothesize that patients with clinically diagnosed neurodegenerative diseases will have significantly different receptor occupancy of 5HT2A receptors compared to a healthy age/sex-matched control group. This will be tested by measuring 5HT2A receptor density using the PET …
Phase: PHASE4 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
New program aims to get veterans with obesity into treatment
Disease control OngoingNearly 8 in 10 Veterans meet criteria for overweight/obesity. Three evidence-based treatment options are available within VA (behavioral weight management \[MOVE!\], obesity medications, and bariatric surgery). However, all treatments are significantly underutilized. This study …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Gut bugs linked to transplant complication risk
Knowledge-focused OngoingRecent published data suggest that specific alterations in intestinal metabolome signature of hematopoietic stem cell transplant (allo-SCT) recipients might influence incidence and severity of acute graft versus host disease (aGVHD). Nevertheless, this possible relationship has n…
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Virtual reality games boost arm recovery after stroke, study finds
Symptom relief CompletedThis study aims to evaluate the effectiveness of Leap Motion-supported virtual reality therapy, applied in addition to traditional rehabilitation programs, in individuals who develop hemiplegia after a cerebrovascular accident. The study will examine the effects of this additiona…
Phase: NA • Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can common drugs boost hand recovery after spinal cord injury?
Symptom relief CompletedThe purpose of this study is to investigate the short-term effects of 3 approved FDA drugs (cyproheptadine (CPH), carbidopa-levodopa (CD-LD), and atomoxetine (ATX)) on motor responses when delivered in combination with hand training exercises in people with chronic spinal cord in…
Phase: PHASE1 • Sponsor: Bronx VA Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can a 9-Minute chat help black adults breathe easier?
Disease control Recruiting nowThis study is an efficacy-implementation trial to: 1. evaluate systematically the efficacy of BREATHE in 200 Black adults receiving care at urban federally qualified health centers (FQHCs) for uncontrolled asthma; and 2. identify multi-level barriers and facilitators to the wide…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New program aims to bring COPD relief to underserved communities
Symptom relief Recruiting nowChronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable ex…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Liver cancer drug combo shows promise but study halted early
Disease control TerminatedThis phase II trial tests whether nivolumab and ipilimumab works to shrink tumors in patients with liver cancer that has spread to nearby tissue or lymph nodes (locally advanced), has spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable).…
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Community health workers take on high blood pressure in detroit and cleveland
Disease control Recruiting nowThis project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities in two cities: Detroit, Michigan, and Cl…
Phase: NA • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could 2 HPV vaccine doses be enough for women 27-45? new trial aims to find out.
Prevention Recruiting nowThe goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferior immune response. Participants will be randomized 1:1 to either the 2-dose group or the 3-dose group and asked to provid…
Phase: PHASE4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Can a 6-Week program ease long COVID? new study tests Day-Hospital care
Symptom relief CompletedAfter an acute episode of COVID-19, many patients experience persistent or recurrent symptoms with substantial impairment of their quality of life. The most common symptoms are fatigue, dyspnea, cognitive impairment and pain, but symptoms of all types have been reported. The hete…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Kidney transplant breakthrough? drug combo aims to reduce lifelong pills
Disease control TerminatedThe purpose of this study is to determine the optimal regimen for the use of siplizumab, a human anti-CD2 antibody, combined with donor bone marrow cells and non-myeloablative conditioning, for tolerance induction in living donor renal transplantation
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC